Back
ADMA Biologics Vs. REV Group Industry Stock Comparison
Buy
64
ADMA
ADMA Biologics
Last Price:
$18.51
Seasonality Move:
5.94%
Buy
77
REVG
REV Group
Last Price:
$48.45
Seasonality Move:
8.66%
Buy
64
ADMA Biologics (ADMA)
is a Buy
Is ADMA Biologics a Buy, Sell or Hold?
-
The current ADMA Biologics [ADMA] share price is $18.51. The Score for ADMA is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
ADMA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ADMA Stock Price Chart
What is ADMA Biologics's stock price today?
-
The ADMA Biologics share price today is $18.51Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADMA is experiencing slight buying pressure.
REVG Stock Price Chart
ADMA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.48 | Sell |
Relative Strength Index (14 RSI): | 46.05 | Sell |
Chaikin Money Flow: | 592928 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.65 - 20.35) | Sell |
Bollinger Bands (100): | (17.37 - 21.51) | Sell |
REVG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 10.9 | Buy |
Relative Strength Index (14 RSI): | 66.78 | Buy |
Chaikin Money Flow: | -105726 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44 - 48.58) | Buy |
Bollinger Bands (100): | (29.95 - 42.85) | Buy |
ADMA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.16 | Buy |
20-day SMA: | 18.55 | Sell |
50-day SMA: | 19.95 | Sell |
200-day SMA: | 18.9 | Sell |
8-day EMA: | 18.28 | Buy |
20-day EMA: | 18.62 | Sell |
50-day EMA: | 19.3 | Sell |
200-day EMA: | 17.95 | Buy |
REVG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.31 | Sell |
20-day SMA: | 46.68 | Buy |
50-day SMA: | 41.64 | Buy |
200-day SMA: | 33.53 | Buy |
8-day EMA: | 31.07 | Buy |
20-day EMA: | 16.19 | Buy |
50-day EMA: | 7.26 | Buy |
200-day EMA: | 1.93 | Buy |
ADMA Biologics Earnings Growth & ADMA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.34 per share.
REV Group Earnings Growth & REVG Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.29 per share, an increase this year of $0.86 per share, and an increase next year of $0.94 per share.
ADMA Biologics Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
REV Group Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |